Co-Diagnostics Share Holder Equity 2017-2024 | CODX

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Co-Diagnostics share holder equity from 2017 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

Co-Diagnostics share holder equity from 2017 to 2024. Share holder equity can be defined as the sum of preferred and common equity items

Related Stocks
Company Name	Market Cap
Elevance Health (ELV)	$125.1B
Cencora (COR)	$45B
ICON (ICLR)	$25B
DiDi Global (DIDIY)	$19B
Avantor (AVTR)	$18.4B
Natera (NTRA)	$15.7B
Revvity (RVTY)	$15.4B
Viatris (VTRS)	$14.2B
CochLear (CHEOY)	$12.8B
Solventum (SOLV)	$12.5B
Medpace Holdings (MEDP)	$11.2B
Charles River Laboratories (CRL)	$10.6B
Sonic Healthcare (SKHHY)	$8.8B
Doximity (DOCS)	$7.4B
Bausch + Lomb (BLCO)	$7B
HealthEquity (HQY)	$6.8B
PACS (PACS)	$6.2B
Organon (OGN)	$5.1B
Life Times (LTH)	$4.9B
Sotera Health (SHC)	$4.7B
Surgery Partners (SGRY)	$4.1B
Concentras Parent (CON)	$3B
GoodRx Holdings (GDRX)	$2.8B
BrightSpring Health Services (BTSG)	$2.5B
Ardent Health Partners (ARDT)	$2.4B
Progyny (PGNY)	$2.2B
Alignment Healthcare (ALHC)	$2.2B
Premier (PINC)	$2.1B
Ryman Healthcare (RYHTY)	$1.9B
AMN Healthcare Services Inc (AMN)	$1.8B